Loading...

CVET - Covetrus, Inc.

Analyst Downgrade Signal for 06-13-2022
Analyst Downgrade Signal: CVET from Buy to Hold by Stifel
Price Target: $22



Stock Signal Information


Signal

Analyst Downgrade Stock
Report Date: 06-13-2022
Symbol: CVET - Covetrus, Inc.
Sector: Healthcare
Industry: Health Information Services
Analyst Downgrade Signal: CVET from Buy to Hold by Stifel
Price Target: $22

  CVET Technical Chart

Company Contact

Covetrus, Inc. (CVET)
7 Custom House St
Portland, MAINE 04101
Phone: 18882802221
Website: http://www.covetrus.com
CEO: Mr. Benjamin Wolin


Company Profile

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins and supplements to wholesale and retail customers. The company also offers value-added practice solutions that include financial services, equipment repair, inventory management, and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as e-commerce, shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company, formerly known as HS Spinco, Inc., was incorporated in 2018 and is headquartered in Portland, Maine.